Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 168

Results For "event"

2077 News Found

Metropolis recognises medical students with scholarship grants and awards
Clinical Trials | March 28, 2022

Metropolis recognises medical students with scholarship grants and awards

Launched in the year 2018, MedEngage Scholarship Program is aimed at nurturing and nourishing medical talent in India


Free guide to Colorectal Cancer Screening now available in Hindi
Healthcare | March 28, 2022

Free guide to Colorectal Cancer Screening now available in Hindi

Colorectal Cancer Screening is now translated into multiple languages to help people worldwide understand why, when and how to screen for colorectal cancer


Live Pharma Coalition organised its first-ever pharma conclave in Mumbai
News | March 28, 2022

Live Pharma Coalition organised its first-ever pharma conclave in Mumbai

It celebrated its 100th session as LPC-100 in association with Mundial Pharma


NATHEALTH 8th annual summit in New Delhi from March 28-29.
News | March 26, 2022

NATHEALTH 8th annual summit in New Delhi from March 28-29.

More than 120 speakers and 5,000 delegates are expected to attend


RCSE partner with Rela Hospitals for  advanced surgical course
Hospitals | March 26, 2022

RCSE partner with Rela Hospitals for advanced surgical course

These courses are for pre-selected candidates who have completed their MBBS with an additional 2 years of surgical experience training


Novavax to participate in two booster studies using its COVID-19 vaccine
Biotech | March 26, 2022

Novavax to participate in two booster studies using its COVID-19 vaccine

U.S. NIAID-sponsored trial will evaluate heterologous booster regimens, including NVX-CoV2373, after primary series with current USFDA approved or emergency use authorized-vaccines


Evusheld recommended for market authorisation in EU
Biotech | March 25, 2022

Evusheld recommended for market authorisation in EU

Recommendation based on Phase III PROVENT trial showing a significant reduction in the risk of developing symptomatic COVID-19, with protection lasting at least six months


USFDA approves Janssen’s injectable regimen for HIV
Drug Approval | March 25, 2022

USFDA approves Janssen’s injectable regimen for HIV

Cabenuva was co-developed as part of a collaboration with ViiV Healthcare and builds on Janssen's decades-long commitment to combatting HIV


Roche to present data across neuroscience portfolio at 2022 AAN Annual Meeting
News | March 25, 2022

Roche to present data across neuroscience portfolio at 2022 AAN Annual Meeting

Additional data across neurological disorders, including Alzheimer’s disease, help advance the scientific understanding of these conditions and the potential impact of early treatment


Seven ways the pharma industry can benefit from tech-driven logistics solutions
Opinion | March 24, 2022

Seven ways the pharma industry can benefit from tech-driven logistics solutions

The next-gen logistics management solutions are making the global supply chains more customer-centric and sustainable